FDA issues update on heart device recall
All hospitals may request a backup controller with modified software for the Heartware Ventricular Assist Device System to use in certain circumstances if the primary controller fails to restart the pump, the Food and Drug Administration announced today. Medtronic last year recalled over 1,600 of the devices because the internal pump may stop and fail to restart, among other safety concerns, but said the risk of removing an implanted device may outweigh the benefits.
Related News Articles
Headline
The Food and Drug Administration the week of Aug. 7 cleared for marketing the first sterilization system for 3D-printed devices in health care facilities. The…
Headline
The Environmental Protection Agency today proposed requiring commercial sterilization facilities to comply within 18 months with stricter emission and…
Headline
Effective today under the Consolidated Appropriations Act of 2023, medical devices seeking approval from the Food and Drug Administration must meet certain…
Headline
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…
Headline
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require…
Headline
The FBI today released recommendations to help protect medical devices from cyberattacks that can threaten health care operations, patient safety, and…